Elevance Health Inc. (ELV)
NYSE: ELV
· Real-Time Price · USD
409.55
1.24 (0.30%)
At close: May 02, 2025, 3:59 PM
408.00
-0.38%
After-hours: May 02, 2025, 05:51 PM EDT
0.30% (1D)
Bid | 408 |
Market Cap | 92.53B |
Revenue (ttm) | 183.12B |
Net Income (ttm) | 5.92B |
EPS (ttm) | 25.68 |
PE Ratio (ttm) | 15.95 |
Forward PE | 10.75 |
Analyst | Buy |
Ask | 411.28 |
Volume | 842,995 |
Avg. Volume (20D) | 1,792,939.8 |
Open | 412.30 |
Previous Close | 408.31 |
Day's Range | 406.37 - 413.38 |
52-Week Range | 362.21 - 567.26 |
Beta | 0.78 |
About ELV
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 20...
Industry Medical - Healthcare Plans
Sector Healthcare
IPO Date Oct 30, 2001
Employees 104,200
Stock Exchange NYSE
Ticker Symbol ELV
Website https://www.elevancehealth.com
Analyst Forecast
According to 15 analyst ratings, the average rating for ELV stock is "Buy." The 12-month stock price forecast is $514, which is an increase of 25.51% from the latest price.
Stock ForecastsEarnings Surprise
Elevance Health has released their quartely earnings
on Apr 22, 2025:
1 week ago
-4.2%
Shares of health insurance stocks are trading lowe...
Unlock content with
Pro Subscription
2 weeks ago
-2.42%
Shares of health insurance stocks are trading lower in sympathy with UnitedHealth, which reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates.